G股叶荣添
08-03
$宝济药业-B(02659)$
全球首款合成生物学重组乌司他丁BJ044获批临床,宝济还是非常可以的,有比较强的基本面
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":592833924589000,"tweetId":"592833924589000","gmtCreate":1785762495807,"gmtModify":1785762497775,"author":{"id":4218001298160580,"idStr":"4218001298160580","authorId":4218001298160580,"authorIdStr":"4218001298160580","name":"G股叶荣添","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":4,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02659\">$宝济药业-B(02659)$ </a> 全球首款合成生物学重组乌司他丁BJ044获批临床,宝济还是非常可以的,有比较强的基本面</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02659\">$宝济药业-B(02659)$ </a> 全球首款合成生物学重组乌司他丁BJ044获批临床,宝济还是非常可以的,有比较强的基本面</p></body></html>","text":"$宝济药业-B(02659)$ 全球首款合成生物学重组乌司他丁BJ044获批临床,宝济还是非常可以的,有比较强的基本面","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/592833924589000","repostId":0,"isVote":1,"tweetType":1,"viewCount":594,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02659"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":98,"optionInvolvedFlag":false,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/592833924589000"}
精彩评论